Newsletter | NOV 2018
Introducing a New Generation of LABScreen Single Antigen
Of all of our upcoming product releases announced at this year’s ASHI meeting, it was news of a new generation of LABScreen Single Antigen supplement kits (in development) that seemed to generate the most interest. We were pleased to have Dr. Debra KuKuruga present preliminary results her team obtained with our new LABScreen Single Antigen supplement kits with interesting case studies highlighting the importance of the additional alleles. Designed for use with the LABScan3D platform, these new kits will allow users to test well beyond the current 100 specificities in a single run.
When released, the new supplement kits will offer several key advantages to the HLA laboratory including:
- Greater Coverage in a single well with over 150 SAB regions.
- Streamlines workflow to reduce labor and assay time.
- Shorter Turnaround time for analysis and reporting.
With this new generation of LABScreen assays right around the corner, we think now is time to make the jump to the LABScan3D. And to make this transition easier, we are offering special pricing on LABScan3D instruments through the end of the year.
To learn more about the new LABScreen Single Antigen Supplemental Kits or take advantage of our LABScan 3D promotion effective through December 31, 2018, please contact your One Lambda representative or One Lambda Marketing.